Bustidin 20 Rousswel medicine for stable angina (2 blisters x 30 tablets)

Dosage form Box of 2 blisters x 30 tablets
Specifications Trimetazidine
Ingredient Angina

Ingredient

Composition information	Content
Trimetazidine	20mg

Uses

indications

Bustidin 20 drugs are indicated for adults in supplementary therapy/support for existing treatments to treat symptoms in stable angina patients with not fully controlled, or non -tolerant patients with head angina treatment therapy.

Pharmacokology

trimetazidin inhibits the oxidation of fatty acids by inhibiting the 3-ketoacyl-coa thiolase enzymes in ischemic cells, energy obtained during glucose oxidation needs to be less than oxygen than oxidative beta. Promoting glucose oxidation will help optimize cell energy processes, thus maintaining appropriate energy metabolism during anemia.

In patients with local heart anemia, trimetazidine acts as a metabolite, which helps conserve high intracellular energy levels in myocardial cell. Trimetazidin has anti -anemia effect but does not affect hemodynamics.

Dynamic pharmacokinetics

After taken, the drug is quickly absorbed and reached the peak concentration in plasma before 2 hours. The drug diffuses well into the tissue, low links to plasma proteins. The sale time is 6 hours. Elimination mainly through urine.

Before taking Bustidin 20 Rousswel medicine for stable angina (2 blisters x 30 tablets)

How to use

oral medication.

Dosage

Take 1 capsule, 3 times a day with meals.

People with average renal failure (Creatinin clearance 30 - 60 ml/minute): take 1 tablet, 2 times a day, morning and evening, use with meals.

Elderly: Drink as directed by the doctor.

Children: There is currently no data on patients under 18 years old.

Note: The above dose is for reference only. Specific dosage depends on the condition and level of progression of the disease. For a suitable dose, you need to consult a doctor or medical specialist.What do

do when using overdose?

What to do when forgetting 1 dose?

Keep the gap between the drug use as directed.

Side Effects

When using Bustidin 20, you may experience unwanted effects (ADR).

Common

Central nervous disorders: dizziness, headache.

Stomach -intestinal disorders: abdominal pain, diarrhea, indigestion, nausea and vomiting.

Disorders on the skin and subcutaneous tissue: rashes, urticaria.

Systemic disorders: weakness.

Rare

Disorders on the heart: Brushing chest drum, nervousness, extra mind, fast heartbeat.

Pentrlower disorders: arterial hypotension, vertical hypotension, which can lead to discomfort, dizziness or falling (especially in patients being treated with anti -hypertension drugs), blushing.

Unknown

Central neurological disorders: Parkinson symptoms (Run, slow movement and difficulty, muscle tone), unstable gait, vacuum syndrome, relevant movement disorders can be recovered after stopping the drug.

Disorders on the stomach - intestines: constipation.

Blood disorders and lymphatic systems: granulocytosis, thrombocytopenia, thrombocytopenia.

Hepatitis: Hepatitis.

Disorders on the skin and subcutaneous tissue: External pustules (AGEP), Evaluation.

Instructions on how to handle ADR

When experiencing side effects of the drug, it is necessary to stop using and notify the doctor or go to the nearest medical facility for timely treatment.

Warnings

Before using the drug you need to read the instructions carefully and refer to the information below.

contraindicated

Bustidin 20 contraindicated drug in the following cases:

Patients with a history of allergies to any ingredients in the formula of the drug.

Parkison patient, Parkinson's symptoms, tremor, vacuum syndrome and other relevant movement disorders.

Severe renal failure (Creatinine clearance

Caution when using

should not be used in the previous stage of hospitalization and the first days of hospitalization. Do not use this medication for patients with chest pain. Do not use this medication to treat unstable angina and myocardial infarction.

Used for the elderly need to check and monitor regularly because trimetazidin can cause or worsen Parkinson's symptoms (Run, move slowly and difficult, increase muscle tone).

Khi gặp phải các rối loạn vận động như các triệu chứng Parkinson, hội chứng chân bứt rứt, run, dáng đi không vững cần ngay lập tức ngừng sử dụng trimetazidin. These cases are rarely occurring and often recover after stopping the drug. Most patients recover after stopping the drug for about 4 months. Nếu các triệu chứng Parkinson tiếp tục xảy ra quá 4 tháng sau khi dừng thuốc, cần tham vấn các bác sĩ chuyên khoa thần kinh.

Patients who are treating hypertension, may experience self, unstable gait or hypotension.

Be careful when prescribing trimetazidin for patients with high sensitivity levels: Patients with average renal impairment, patients over 75 years old.

Due to lactose-containing drug ingredients, this drug should not be used for patients with rare genetic diseases, causing galactose tolerance, lactase deficiency or glucose-galactose.

ponaceau 4r, erythrosin red in the drug composition can cause allergic reactions.

The ability to drive and operate machinery

trimetazidin can cause symptoms such as dizziness and drowsiness, so it can affect the ability to drive and operate machinery.

The best pregnancy

does not take the drug during pregnancy.

breastfeeding period

should not breastfeed during treatment.

Interactive drug

There has been no interaction of trimetazidin dihydrochloride with other drugs.

Storage

Store in a cool dry place, temperatures below 30 ° C, avoiding light.

To be out of reach of children.

Other drugs

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.